Repligen | Eiendeler

Assets Endring Dato
Agilent USD 10.86B 92M 2024-04
Align Technology USD 6.16B 71.88M 2024-03
Bio Techne USD 2.72B 9.58M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Bruker USD 4.51B 267.6M 2024-03
Catalent USD 9.88B 109M 2024-03
Charles River Laboratories USD 8.15B 42.22M 2024-03
Danaher USD 83.4B 1.09B 2024-03
Dentsply International USD 7.12B 247M 2024-03
Exact Sciences USD 6.38B 95.01M 2024-03
General Electric USD 163.94B 897M 2024-03
Henry Schein USD 10.15B 428M 2024-03
Illumina USD 10.04B 71M 2024-03
IQVIA Holdings USD 26.57B 107M 2024-03
Mettler Toledo International USD 3.28B 72.44M 2024-03
Myriad Genetics USD 1.11B 36M 2024-03
Patterson Companies USD 2.94B 50.26M 2024-01
Pfizer USD 221.1B 6.07B 2024-03
Repligen USD 2.85B 1.9B 2024-03
Revvity USD 13.43B 131.96M 2024-03
Standard Biotools USD 777.67M 454.6M 2024-03
Thermo Fisher Scientific USD 97.1B 1.63B 2024-03
Waters USD 4.63B 129.67M 2023-12
West Pharmaceutical Services USD 3.6B 152.4M 2024-03



Repligen Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.